COVID-19 vaccine breakthrough infections | Science
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
Covid-19 vaccine mixing: could heterologous boosters improve immunity?
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
COVID-19 Vaccines and Booster Shots: Which Combination is Most Effective? - Homage
Moderna COVID vaccine booster dose results in immune memory
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
Covid booster vaccines effective against severe illness from omicron, CDC says
Why are COVID-19 vaccine booster shots so complicated? - Los Angeles Times
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Comparative Effectiveness of Pfizer and Moderna COVID-19 Vaccines for Boosting | Bennett Institute for Applied Data Science
Updated COVID booster tied to strong Omicron immune response | CIDRAP
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021 | MMWR
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021 | MMWR
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England | Nature Medicine
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | MMWR
Who Is Eligible for a COVID-19 Booster?
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Covid booster vaccines effective against severe illness from omicron, CDC says
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
